insight

Mor N ⚠ 동명이인 가능성

제1저자 또는 공저자로 매칭된 논문 · word-boundary on `authors` column

이름 + 이니셜 1자만으로는 동명이인 구분이 어렵습니다. 상세 비교는 Mor N 비교 뷰 →

3 논문
2016–2018 활동기
PubMed [au] 검색 ↗ Google Scholar ↗

주요 저널

  • The Laryngoscope 2
  • Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1

주요 카테고리

보툴리눔독소 주사 (2)

주요 공저자 Top 5

  1. Blitzer A 3편
  2. Simonyan K 1편
  3. Tang CG 1편
  4. Novakovic D 1편
  5. Tang C 1편

연도별 분포

  • 2018 1
  • 2016 2

최근 발표

2018 The Laryngoscope
Central voice production and pathophysiology of spasmodic dysphonia.
Mor N · 제1저자
2016 The Laryngoscope
Onabotulinum toxin A dosage trends over time for adductor spasmodic dysphonia: A 15-year experience.
Tang CG 외
2016 Otolaryngology--head and neck surger…
Botulinum Toxin in Secondarily Nonresponsive Patients with Spasmodic Dysphonia.
Mor N · 제1저자

공저자 네트워크

중심 = Mor N · 공저 횟수 상위 30명
— 편 — 공저자 — 엣지
본인 공저자 본인-공저자 공저자 사이
⏳ 그래프 로딩 중…

노드 더블클릭 = 해당 저자 페이지로 이동 · 호버 = 공저 횟수 툴팁

논문 목록

3건 · 최신순
  • Central voice production and pathophysiology of spasmodic dysphonia.
    The Laryngoscope 2018 Mor N (제1저자) PMID: 28543038

    [OBJECTIVE] Our ability to speak is complex, and the role of the central nervous system in controlling speech production is often overlooked in the field of otolaryngology. In this brief review, we present an integrated overview of speech p…

  • Onabotulinum toxin A dosage trends over time for adductor spasmodic dysphonia: A 15-year experience.
    The Laryngoscope 2016 Tang CG 외 PMID: 26308153

    [OBJECTIVES/HYPOTHESIS] Although onabotulinum neurotoxin A (BoNTA) has been used for over three decades for the treatment of adductor spasmodic dysphonia, no study has been performed to look at the trend of BoNTA dosages across time. The go…

  • Botulinum Toxin in Secondarily Nonresponsive Patients with Spasmodic Dysphonia.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2016 Mor N (제1저자) PMID: 27143711

    Chemodenervation with botulinum toxin (BoNT) has been effective and well tolerated for all types of dystonia for >30 years. We reviewed outcomes of our patients treated with BoNT serotype A (BoNT-A) for spasmodic dysphonia (SD) who became s…